» Articles » PMID: 30462740

Pulmonary Isolation and Clinical Relevance of Nontuberculous Mycobacteria During Nationwide Survey in Serbia, 2010-2015

Overview
Journal PLoS One
Date 2018 Nov 22
PMID 30462740
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The rates of pulmonary colonization and disease due to nontuberculous mycobacteria (NTM) appear to be increasing globally, but diversity of species recovered as well as clinical relevance of NTM isolates differ considerably by geographic region. The first nationwide study of isolation frequency and clinical significance of NTM in Serbia included all patients with respiratory specimens yielding a positive NTM culture over the six-year period, 2010-2015. We analyzed trends in annual NTM isolation and NTM pulmonary disease (PD) incidence rates, with NTM PD cases defined in accordance with microbiological criteria established by the American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA). 777 pulmonary NTM isolates were collected from 565 patients, of whom 126 (22.3%) met the ATS/IDSA criteria. The annual NTM isolation and NTM PD incidence rates per 100,000 changed over 2010-2015 from 0.9 to 1.6 (p = 0.1746) and from 0.18 to 0.48 (p = f0.0040), respectively. Both isolation and disease rates increased considerably with age, while higher NTM PD rates were also associated with residence in urbanized areas. Diversity of NTM species isolated was shown to be region-specific, with M. xenopi as the most prevalent species (17.3%), and increasing isolation rates of rapid growing mycobacteria (RGM) (p = 0.0072). M. xenopi was also the most common cause of NTM PD (28.6%), followed by RGM (27.8%). With 73% clinically relevant isolates, M. abscessus was identified as the most clinically relevant NTM species. While NTM PD obviously remains a rare disease in Serbia, the overall results justify recognition of NTM as pathogens of rising importance, and require further characterization of their epidemiology in the country.

Citing Articles

Nontuberculous Mycobacteria Isolates in Respiratory Samples and Mycobacterial Pulmonary Disease in an Area of Northern Spain.

Ugedo J, Tabernero E, Altube L, Leal M, Garcia J Open Respir Arch. 2024; 6(4):100353.

PMID: 39318829 PMC: 11421231. DOI: 10.1016/j.opresp.2024.100353.


Nontuberculous mycobacterial infection in Wisconsin children and adolescents.

Vonasek B, Gusland D, Tans-Kersten J, Misch E, Gibbons-Burgener S J Clin Tuberc Other Mycobact Dis. 2024; 36:100456.

PMID: 38974997 PMC: 11227012. DOI: 10.1016/j.jctube.2024.100456.


Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease: A Review.

Prevots D, Marshall J, Wagner D, Morimoto K Clin Chest Med. 2023; 44(4):675-721.

PMID: 37890910 PMC: 10625169. DOI: 10.1016/j.ccm.2023.08.012.


Nontuberculous Mycobacterial Infection in Wisconsin Adults and Its Relationship to Race and Social Disadvantage.

Vonasek B, Gusland D, Hash K, Wiese A, Tans-Kersten J, Astor B Ann Am Thorac Soc. 2023; 20(8):1107-1115.

PMID: 36812384 PMC: 10405610. DOI: 10.1513/AnnalsATS.202205-425OC.


The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults.

Khan O, Chaudary N Drug Des Devel Ther. 2020; 14:2287-2294.

PMID: 32606598 PMC: 7293904. DOI: 10.2147/DDDT.S146111.

References
1.
Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P . The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013; 42(6):1604-13. DOI: 10.1183/09031936.00149212. View

2.
Jankovic M, Samarzija M, Sabol I, Jakopovic M, Jankovic V, Zmak L . Geographical distribution and clinical relevance of non-tuberculous mycobacteria in Croatia. Int J Tuberc Lung Dis. 2013; 17(6):836-41. DOI: 10.5588/ijtld.12.0843. View

3.
Simons S, van Ingen J, Hsueh P, Van Hung N, Dekhuijzen P, Boeree M . Nontuberculous mycobacteria in respiratory tract infections, eastern Asia. Emerg Infect Dis. 2011; 17(3):343-9. PMC: 3165997. DOI: 10.3201/eid1703.100604. View

4.
Wu J, Zhang Y, Li J, Lin S, Wang L, Jiang Y . Increase in nontuberculous mycobacteria isolated in Shanghai, China: results from a population-based study. PLoS One. 2014; 9(10):e109736. PMC: 4199589. DOI: 10.1371/journal.pone.0109736. View

5.
Rindi L, Garzelli C . Increase in non-tuberculous mycobacteria isolated from humans in Tuscany, Italy, from 2004 to 2014. BMC Infect Dis. 2016; 16:44. PMC: 4736237. DOI: 10.1186/s12879-016-1380-y. View